PepDiana
Back to Evidence
Primary experimental recordPositive observation

PMC13118935::ACT043872

Angiotensin II

Evidence text

Paper-level observation

Ang II-loaded NLCs (9.35 ± 1.36%) after 2 h
textConfidence: medium

Assay observation

Activity
Other
Subtype
Other
Measure
other
Comparator
=
Raw observation
9.35 ± 1.36% (percent_permeation)
Normalized measurement
=9.35%
Value minimum
7.99%
Value maximum
10.71%
Target
Sus scrofa
Assay method
Not reported by source
Sequence
DRVYIHPF
Standardization
ready simple

Source publication

Ex Vivo Buccal Permeability of Nanostructured Lipid Carriers (NLCs) Associated with a Peptide Drug Model.

Pharmaceutics · 2026

DOI 10.3390/pharmaceutics18040416 PMC13118935
Parent mention Integrated peptide

Related peptide identities

PEPDIA-PLP-003453PEPDIA-INT-038027

Release PepDiana-V1-20260620. The stable record URL can be cited directly in supplementary material and downstream analyses.